While many once-deadly infectious diseases are now manageable, some remain incurable. This article explores the few remaining 100% fatal infectious diseases, their mechanisms, and the ongoing research to combat them.
Results for: Infectious Diseases
Convivio 2024, a charity initiative dedicated to raising funds for HIV and infectious diseases, concluded its special edition with a magical fundraising dinner. Held at Fabbrica del Vapore in Milan, the event raised a record-breaking €1.8 million through a week-long shopping event and a dazzling gala dinner. The event featured unique table settings inspired by the theme of magic, showcasing the creativity and commitment of participating brands and sponsors.
The global anti-infective drugs market is projected to experience substantial growth, reaching US$ 177.9 billion by 2031, driven by factors such as the increasing prevalence of infectious diseases, rising awareness of hygiene and prevention, advancements in drug development, and the growing threat of antimicrobial resistance.
The global mycoplasma diagnostics market is experiencing a surge in demand, driven by factors such as the escalating threat of antimicrobial resistance, increasing prevalence of mycoplasma infections, and advancements in diagnostic technologies. This market is projected to reach US$ 2.1 billion by 2034, with a robust CAGR of 7.4%. This comprehensive report analyzes the key market drivers, competitive landscape, regional profiles, and future growth prospects.
Oropouche virus, sometimes called ‘sloth virus,’ is a Zika-like illness spreading in the Americas. The virus has been detected in travelers returning to the US and Europe, raising concerns about its potential impact. While most cases are mild, pregnant women are advised to be especially cautious as there is a potential risk of birth defects. This article provides information on the virus, its symptoms, transmission, and prevention measures.
The Biden administration’s immigration policies have resulted in millions of unvaccinated migrants entering the United States, leading to a resurgence of preventable infectious diseases. These diseases are not only infecting migrants themselves but also spreading to the broader population, including school children and healthcare workers. The article argues that it is crucial to vaccinate all illegal immigrants to protect public health, save lives, and reduce healthcare costs.
Nipah virus, a deadly infection of the brain, has no licensed treatment or vaccine. However, a recent study has presented a potential game-changer for future treatment options. Scientists compared the effectiveness of two different monoclonal antibodies against Nipah virus, and the results showed that a new antibody, hu1F5, was highly effective in protecting African green monkeys from the virus. This study provides promise for potential future testing of the hu1F5 monoclonal antibody in humans and highlights the importance of continued research in the fight against emerging infectious diseases.